| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Division of Medical Genetics, University of Washington, Seattle, Washington 98195
Targeting of oncolytic adenoviruses to tumors can potentially increase their efficacy and safety profile after systemic application. We have developed recently a capsid-modified vector containing the adenovirus serotype 35 fiber shaft and knob inserted into an Ad5 capsid. This Ad5/35 vector infects cells via a coxsackievirus adenovirus receptor-independent pathway. Here we attempted to exploit this new tropism of Ad5/35 vectors for tumor-specific infection. In vitro, the Ad5/35 vector efficiently transduced human breast cancer cells that were refractory to infection with conventional Ad5-based vectors. Additionally, primary mouse hepatocytes were relatively refractory to Ad5/35 infection in vitro or after systemic vector application to mice. In an animal model of breast cancer metastasis, intraportal infusion of MDA-MB435 cells produced multiple hepatic metastases that were surrounded by extracellular matrix and developed blood vessels confined to the tumor stroma. Tail vein injection of a standard Ad5-based vector into tumor-bearing animals resulted in transduction of mouse hepatocytes but not metastases. However, the capsid-modified Ad5/35 vector transduced only 
8% of metastases. The metastases that were susceptible to Ad5/35 infection demonstrated blood vessels in close proximity to tumor nests without extracellular matrix separating endothelial and tumor cells. These findings indicate that transduction of liver metastases not only requires tumor-specific tropism but also new strategies to increase accessibility of tumor cells to systemically applied oncolytic adenoviruses.
This article has been cited by other articles:
|
|
 |
|
  D. Kolodkin-Gal, G. Zamir, Y. Edden, E. Pikarsky, A. Pikarsky, H. Haim, Y. S. Haviv, and A. Panet Herpes Simplex Virus Type 1 Preferentially Targets Human Colon Carcinoma: Role of Extracellular Matrix J. Virol., January 15, 2008; 82(2): 999 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Y. Logunov, O. V. Zubkova, A. S. Karyagina-Zhulina, E. A. Shuvalova, A. P. Karpov, M. M. Shmarov, I. L. Tutykhina, Y. S. Alyapkina, N. M. Grezina, N. A. Zinovieva, et al. Identification of HI-Like Loop in CELO Adenovirus Fiber for Incorporation of Receptor Binding Motifs J. Virol., September 15, 2007; 81(18): 9641 - 9652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Waddington, A. L. Parker, M. Havenga, S. A. Nicklin, S. M. K. Buckley, J. H. McVey, and A. H. Baker Targeting of Adenovirus Serotype 5 (Ad5) and 5/47 Pseudotyped Vectors In Vivo: Fundamental Involvement of Coagulation Factors and Redundancy of CAR Binding by Ad5 J. Virol., September 1, 2007; 81(17): 9568 - 9571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J.V. Vaha-Koskela, J. P. Kallio, L. C. Jansson, J. E. Heikkila, V. A. Zakhartchenko, M. A. Kallajoki, V.-M. Kahari, and A. E. Hinkkanen Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice. Cancer Res., July 15, 2006; 66(14): 7185 - 7194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shayakhmetov, A. Gaggar, S. Ni, Z.-Y. Li, and A. Lieber Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity J. Virol., June 15, 2005; 79(12): 7478 - 7491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Shayakhmetov, Z.-Y. Li, S. Ni, and A. Lieber Interference with the IL-1-Signaling Pathway Improves the Toxicity Profile of Systemically Applied Adenovirus Vectors J. Immunol., June 1, 2005; 174(11): 7310 - 7319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Stone, S. Ni, Z.-Y. Li, A. Gaggar, N. DiPaolo, Q. Feng, V. Sandig, and A. Lieber Development and Assessment of Human Adenovirus Type 11 as a Gene Transfer Vector J. Virol., April 15, 2005; 79(8): 5090 - 5104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shayakhmetov, A. M. Eberly, Z.-Y. Li, and A. Lieber Deletion of Penton RGD Motifs Affects the Efficiency of both the Internalization and the Endosome Escape of Viral Particles Containing Adenovirus Serotype 5 or 35 Fiber Knobs J. Virol., January 15, 2005; 79(2): 1053 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Yotnda, B. Savoldo, N. Charlet-Berguerand, C. Rooney, and M. Brenner Targeted delivery of adenoviral vectors by cytotoxic T cells Blood, October 15, 2004; 104(8): 2272 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shayakhmetov, Z.-Y. Li, A. Gaggar, H. Gharwan, V. Ternovoi, V. Sandig, and A. Lieber Genome Size and Structure Determine Efficiency of Postinternalization Steps and Gene Transfer of Capsid-Modified Adenovirus Vectors in a Cell-Type-Specific Manner J. Virol., September 15, 2004; 78(18): 10009 - 10022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shayakhmetov, Z.-Y. Li, S. Ni, and A. Lieber Analysis of Adenovirus Sequestration in the Liver, Transduction of Hepatic Cells, and Innate Toxicity after Injection of Fiber-Modified Vectors J. Virol., May 15, 2004; 78(10): 5368 - 5381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sirena, B. Lilienfeld, M. Eisenhut, S. Kalin, K. Boucke, R. R. Beerli, L. Vogt, C. Ruedl, M. F. Bachmann, U. F. Greber, et al. The Human Membrane Cofactor CD46 Is a Receptor for Species B Adenovirus Serotype 3 J. Virol., May 1, 2004; 78(9): 4454 - 4462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vogels, D. Zuijdgeest, R. van Rijnsoever, E. Hartkoorn, I. Damen, M.-P. de Bethune, S. Kostense, G. Penders, N. Helmus, W. Koudstaal, et al. Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity J. Virol., August 1, 2003; 77(15): 8263 - 8271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shayakhmetov, Z.-Y. Li, V. Ternovoi, A. Gaggar, H. Gharwan, and A. Lieber The Interaction between the Fiber Knob Domain and the Cellular Attachment Receptor Determines the Intracellular Trafficking Route of Adenoviruses J. Virol., March 15, 2003; 77(6): 3712 - 3723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kawakami, H. Li, J. T. Lam, V. Krasnykh, D. T. Curiel, and J. L. Blackwell Substitution of the Adenovirus Serotype 5 Knob with a Serotype 3 Knob Enhances Multiple Steps in Virus Replication Cancer Res., March 15, 2003; 63(6): 1262 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hemminki, A. Kanerva, B. Liu, M. Wang, R. D. Alvarez, G. P. Siegal, and D. T. Curiel Modulation of Coxsackie-Adenovirus Receptor Expression for Increased Adenoviral Transgene Expression Cancer Res., February 15, 2003; 63(4): 847 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Bernt, D. S. Steinwaerder, S. Ni, Z.-Y. Li, S. R. Roffler, and A. Lieber Enzyme-activated Prodrug Therapy Enhances Tumor-specific Replication of Adenovirus Vectors Cancer Res., November 1, 2002; 62(21): 6089 - 6098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bernt, M. Liang, X. Ye, S. Ni, Z.-Y. Li, S. L. Ye, F. Hu, and A. Lieber A New Type of Adenovirus Vector That Utilizes Homologous Recombination To Achieve Tumor-Specific Replication J. Virol., October 2, 2002; 76(21): 10994 - 11002. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
